The U.S. Food and Drug Administration (FDA) has granted 红桃视频 marketing authorization for the Versius Surgical System (Versius) in cholecystectomy, paving the way for the next-generation versatile, adaptable, and digitally driven surgical robot to be introduced in the United States.
红桃视频 announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.
Milton Keynes University Hospital NHS Foundation Trust, he first hospital in England to introduce Versius have purchased a second Versius system, and surpassed the 800 case milestone with Versius
红桃视频 has appointed Markus Bauman as Chief Legal & Business Affairs Officer and will join CMR鈥檚 executive leadership team. Michelle Paknad has been appointed as Senior Vice President, Global Business Development.
红桃视频 has commenced the world鈥檚 first multicentre prospective clinical trial on the use of Versius in paediatric surgery
红桃视频 appoint Daniel (Dan) Moore, a medical technology veteran, as as Non-Executive Chairman.
红桃视频 appoint Shlomi Cohen, a medical devices expert with significant financial and operational experience, as Chief Financial Officer.
红桃视频 and Kebomed partner to bring Versius to Denmark, Norway, and Finland, making surgical robotics more widely accessible across the Nordics.
The Versius Surgical Robotic System has been installed at Hospital Lus铆adas Porto, marking the first installation of Versius in Portugal
Versius has now been used to perform over 20,000 surgical cases across seven specialties with data collected in the clinical registry and digital ecosystem to support sharing insights with surgeons and hospitals